New antithrombotic and antiplatelet treatment

被引：2

作者：

Neuhaus, KL ^{[1
]}

机构：

[1] Stadt Kliniken, CA Med Klin 2, D-34125 Kassel, Germany

来源：

HEART | 1999年 / 82卷

关键词：

D O I：

10.1136/hrt.82.2008.i8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：I8 / I11

页数：4

共 22 条

[1] ADJUNCTIVE THROMBOLYTIC THERAPY DURING ANGIOPLASTY FOR ISCHEMIC REST ANGINA - RESULTS OF THE TAUSA TRIAL [J].

AMBROSE, JA ;

ALMEIDA, OD ;

SHARMA, SK ;

TORRE, SR ;

MARMUR, JD ;

ISRAEL, DH ;

RATNER, DE ;

WEISS, MB ;

HJEMDAHLMONSEN, CE ;

MYLER, RK ;

MOSES, J ;

UNTERECKER, WJ ;

GRUNWALD, AM ;

GARRETT, JS ;

COWLEY, MJ ;

ANWAR, A ;

SOBOLSKI, J .

CIRCULATION, 1994, 90 (01) :69-77

[2] HIRUDIN IN ACUTE MYOCARDIAL-INFARCTION - SAFETY REPORT FROM THE THROMBOLYSIS AND THROMBIN INHIBITION IN MYOCARDIAL-INFARCTION (TIMI)-9A TRIAL [J].

ANTMAN, EM .

CIRCULATION, 1994, 90 (04) :1624-1630

[3]

Bata I, 1997, CIRCULATION, V96, P769

[4]

Bazzino O, 1998, NEW ENGL J MED, V338, P1498

[5]

BRAUNWALD E, 1994, CIRCULATION, V89, P1545

[6]

BRAUNWALD E, 1993, CIRCULATION, V87, P38

[7] A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease [J].

Cohen, M ;

Demers, C ;

Gurfinkel, EP ;

Turpie, AGG ;

Fromell, GJ ;

Goodman, S ;

Langer, A ;

Califf, RM ;

Fox, KAA ;

Premmereur, J ;

Bigonzi, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (07) :447-452

[8]

*GLOB US STRAT OP, 1996, NEW ENGL J MED, V29, P775

[9]

Harrington R. A., 1997, Journal of the American College of Cardiology, V29, p409A

[10] Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety [J].

Hirsh, J ;

Warkentin, TE ;

Raschke, R ;

Granger, C ;

Ohman, EM ;

Dalen, JE .

CHEST, 1998, 114 (05) :489S-510S

← 1 2 3 →